Development pipeline
CellTran is actively developing treatments based on our patented platform technologies for the following applications:
Dry-delivered Autologous cell therapy
A freeze-dried autologous product, which will simplify application and extend the use of cell-therapy into non-clinical contexts.
Corneal cell delivery
A product for the treatment of corneal defects, which will allow autologous corneal cells to be delivered via a coated release substrate. This product is being developed in conjunction with the Institute of Opthalmology, University College London.
Vitiligo treatment
A product for the treatment of vitiligo delivering both autologous melanocytes and keratinocytes to affected areas of the skin.
Allogeneic cell therapy
An off the shelf product for rapid first-aid treatment of scalds, which will incorporate the delivery of donor cells.
Celltran Limited
The Innovation Centre
217 Portobello
Sheffield, S1 4DP
T: +44 (0)114 2220980
e: info@celltran.com
